Trending Topics
Sensex Live
AI Impact Summit Live
Gold Rate Today
Gold ETF
Omnitech Engineering IPO

Hold Ranbaxy Laboratories; target Rs 465: Unicon Investment

Unicon Investment has recommended hold rating on Ranbaxy Laboratories with a target price of Rs 465, in its February 24, 2012 research report.

February 25, 2012 / 17:09 IST
Story continues below Advertisement
Remove Ad

Unicon Investment has recommended hold rating on Ranbaxy Laboratories with a target price of Rs 465, in its February 24, 2012 research report.

Read More

first published: Feb 25, 2012 05:05 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Today AI Summit 2026 Live Gold Silver Price Small Cap Funds Madam Zeher arrested Prince Andrew Donald Trump Palm Beach Airport Imran Khan Novartis India share price
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds Silver MCX Price Gold MCX Price
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.